ANKAR
gene geneOn this page
Also known as FLJ25415
Summary
ANKAR (ankyrin and armadillo repeat containing, HGNC:26350) is a protein-coding gene on chromosome 2q32.2, encoding Ankyrin and armadillo repeat-containing protein (Q7Z5J8).
Predicted to be located in membrane.
Source: NCBI Gene 150709 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 301 total — 7 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_001378068
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26350 |
| Approved symbol | ANKAR |
| Name | ankyrin and armadillo repeat containing |
| Location | 2q32.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25415 |
| Ensembl gene | ENSG00000151687 |
| Ensembl biotype | protein_coding |
| OMIM | 609803 |
| Entrez | 150709 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 4 protein_coding_CDS_not_defined, 3 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000313581, ENST00000433782, ENST00000441800, ENST00000461516, ENST00000464687, ENST00000467927, ENST00000474303, ENST00000476208, ENST00000520309, ENST00000684021
RefSeq mRNA: 2 — MANE Select: NM_001378068
NM_001378068, NM_144708
CCDS: CCDS33351
Canonical transcript exons
ENST00000684021 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001772368 | 189676456 | 189677091 |
| ENSE00002258738 | 189730495 | 189730601 |
| ENSE00002279237 | 189733107 | 189733229 |
| ENSE00002324359 | 189728267 | 189728420 |
| ENSE00002462463 | 189694981 | 189695161 |
| ENSE00002462766 | 189696150 | 189696369 |
| ENSE00002467490 | 189692255 | 189692418 |
| ENSE00002471742 | 189693074 | 189693177 |
| ENSE00002474032 | 189705023 | 189705224 |
| ENSE00002523861 | 189711049 | 189711153 |
| ENSE00002523920 | 189727856 | 189728097 |
| ENSE00002527278 | 189720619 | 189720787 |
| ENSE00003551438 | 189706938 | 189707146 |
| ENSE00003563557 | 189689527 | 189689964 |
| ENSE00003569856 | 189738565 | 189738682 |
| ENSE00003587008 | 189728660 | 189728821 |
| ENSE00003626412 | 189744742 | 189744788 |
| ENSE00003656653 | 189743275 | 189743474 |
| ENSE00003660070 | 189741342 | 189741451 |
| ENSE00003670923 | 189737683 | 189737841 |
| ENSE00003679785 | 189719572 | 189719813 |
| ENSE00003918477 | 189746380 | 189746647 |
| ENSE00003919820 | 189674670 | 189674830 |
Expression profiles
Bgee: expression breadth ubiquitous, 163 present calls, max score 93.70.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.8167 / max 64.1693, expressed in 1426 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 24256 | 2.2911 | 1069 |
| 24254 | 1.9225 | 719 |
| 24255 | 0.5783 | 279 |
| 24253 | 0.0249 | 3 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 93.70 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.27 | gold quality |
| left ovary | UBERON:0002119 | 80.89 | gold quality |
| tibial nerve | UBERON:0001323 | 80.35 | gold quality |
| popliteal artery | UBERON:0002250 | 80.08 | gold quality |
| tibial artery | UBERON:0007610 | 80.06 | gold quality |
| body of uterus | UBERON:0009853 | 80.05 | gold quality |
| sural nerve | UBERON:0015488 | 79.84 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 79.76 | gold quality |
| right uterine tube | UBERON:0001302 | 79.68 | gold quality |
| right ovary | UBERON:0002118 | 79.44 | gold quality |
| left testis | UBERON:0004533 | 79.19 | gold quality |
| aorta | UBERON:0000947 | 79.17 | gold quality |
| right testis | UBERON:0004534 | 79.14 | gold quality |
| body of pancreas | UBERON:0001150 | 79.08 | gold quality |
| endocervix | UBERON:0000458 | 78.82 | gold quality |
| ascending aorta | UBERON:0001496 | 78.50 | gold quality |
| thoracic aorta | UBERON:0001515 | 78.49 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 78.44 | gold quality |
| adrenal tissue | UBERON:0018303 | 78.33 | gold quality |
| left coronary artery | UBERON:0001626 | 78.31 | gold quality |
| right coronary artery | UBERON:0001625 | 77.87 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 77.87 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 77.84 | gold quality |
| mucosa of stomach | UBERON:0001199 | 77.64 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 77.62 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 77.39 | gold quality |
| ectocervix | UBERON:0012249 | 77.37 | gold quality |
| lower esophagus | UBERON:0013473 | 77.36 | gold quality |
| testis | UBERON:0000473 | 77.07 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.48 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ankar | ENSDARG00000000516 |
| mus_musculus | Ankar | ENSMUSG00000039342 |
| rattus_norvegicus | Ankar | ENSRNOG00000003991 |
| drosophila_melanogaster | arm | FBGN0000117 |
| caenorhabditis_elegans | hmp-2 | WBGENE00001979 |
Paralogs (4): ARMC3 (ENSG00000165309), CTNNB1 (ENSG00000168036), ODAD2 (ENSG00000169126), JUP (ENSG00000173801)
Protein
Protein identifiers
Ankyrin and armadillo repeat-containing protein — Q7Z5J8 (reviewed: Q7Z5J8)
All UniProt accessions (2): Q7Z5J8, E7EWS1
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Tissue specificity. Ubiquitously expressed with highest level in pancreas and lowest in skeletal muscle.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z5J8-1 | 1, FLJ25415-2P | yes |
| Q7Z5J8-2 | 2 | |
| Q7Z5J8-3 | 3 | |
| Q7Z5J8-4 | 4 |
RefSeq proteins (2): NP_001364997, NP_653309 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000225 | Armadillo | Repeat |
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR011989 | ARM-like | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR043379 | ANKAR | Family |
Pfam: PF00514, PF12796
UniProt features (29 total): repeat 11, splice variant 9, sequence conflict 5, sequence variant 2, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z5J8-F1 | 84.79 | 0.53 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 15 (showing top):
IGLV5_37_TARGET_GENES, PAX3_TARGET_GENES, UBN1_TARGET_GENES, ZNF711_TARGET_GENES, BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP, MANNO_MIDBRAIN_NEUROTYPES_HGABA, LHX2_TARGET_GENES, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN, chr2q32, ZNF320_TARGET_GENES, GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN, GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP, GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP, GSE37532_WT_VS_PPARG_KO_LN_TREG_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
564 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ANKAR | OSGEPL1 | Q9H4B0 | 932 |
| ANKAR | TMF1 | P82094 | 820 |
| ANKAR | NEMP2 | A6NFY4 | 661 |
| ANKAR | ORMDL1 | Q9P0S3 | 605 |
| ANKAR | WDR75 | Q8IWA0 | 511 |
| ANKAR | DIRC1 | Q969H9 | 507 |
| ANKAR | IGFALS | P35858 | 482 |
| ANKAR | NFATC2 | Q13469 | 465 |
| ANKAR | SLC68A1 | Q14CX5 | 455 |
| ANKAR | PMS1 | P54277 | 452 |
| ANKAR | USF3 | Q68DE3 | 447 |
| ANKAR | C17orf67 | Q0P5P2 | 446 |
| ANKAR | FBXL15 | Q9H469 | 440 |
| ANKAR | AKAP19 | P0C876 | 432 |
| ANKAR | UBXN2B | Q14CS0 | 425 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IQCB1 | PCP4L1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): ANKAR (Affinity Capture-RNA), SNRPB (Cross-Linking-MS (XL-MS)), MICAL3 (Cross-Linking-MS (XL-MS)), RPL31 (Cross-Linking-MS (XL-MS)), ANKAR (Cross-Linking-MS (XL-MS)), EEF1G (Cross-Linking-MS (XL-MS)), ANKAR (Affinity Capture-MS)
ESM2 similar proteins: A1Z8X3, A2RT91, A5D8W1, A6NKT7, B0CM26, B0VXE6, B1WBT0, C9JQI7, F4JY37, G5ED39, H2QII6, O01510, O08662, O14715, O43065, O94324, P0DJD0, P0DJD1, P12798, P32333, P40955, P45964, P49792, Q01015, Q03280, Q03569, Q0IEK6, Q10122, Q13535, Q17551, Q177G4, Q18508, Q21920, Q4UKJ5, Q5K6N0, Q5S007, Q60J38, Q70PP2, Q756G2, Q7TSH2
Diamond homologs: A2RT91, Q3SX45, Q7Z5J8, A6NK59, P0C927, Q08DV6, Q3V096, Q58CT0, Q5U2S6, Q8C6Y6, Q8HXA6, Q8K0L0, Q8N9B4, Q8VHS6, Q8WXK1, Q96Q27, Q9WV72, Q9WV74, Q9Y575, Q9Y576
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
301 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 7 |
| Likely pathogenic | 1 |
| Uncertain significance | 221 |
| Likely benign | 15 |
| Benign | 13 |
Top pathogenic / likely-pathogenic (8)
| Variant ID | HGVS | Classification |
|---|---|---|
| 146486 | GRCh38/hg38 2q32.2(chr2:188947503-189689613)x1 | Pathogenic |
| 146616 | GRCh38/hg38 2q32.1-33.1(chr2:186027472-201059372)x1 | Pathogenic |
| 149200 | GRCh38/hg38 2q31.3-32.3(chr2:181758701-192015392)x1 | Pathogenic |
| 153288 | GRCh38/hg38 2q31.2-32.3(chr2:177827730-195125329)x1 | Pathogenic |
| 1807826 | GRCh37/hg19 2q32.1-33.1(chr2:187152754-199960525)x1 | Pathogenic |
| 58771 | GRCh38/hg38 2q31.2-33.1(chr2:177874070-198525492)x1 | Pathogenic |
| 977790 | GRCh37/hg19 2q32.2-33.1(chr2:190345272-200212289) | Pathogenic |
| 979391 | GRCh37/hg19 2q32.1-33.1(chr2:188294864-197731939)x3 | Likely pathogenic |
SpliceAI
4588 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:189689625:GCT:G | donor_gain | 1.0000 |
| 2:189692250:T:TA | acceptor_gain | 1.0000 |
| 2:189705220:GCTGA:G | donor_gain | 1.0000 |
| 2:189705221:C:G | donor_gain | 1.0000 |
| 2:189705225:G:GG | donor_gain | 1.0000 |
| 2:189707042:G:GT | donor_gain | 1.0000 |
| 2:189752651:A:AC | donor_gain | 1.0000 |
| 2:189752652:C:CC | donor_gain | 1.0000 |
| 2:189753910:ACTT:A | donor_loss | 1.0000 |
| 2:189753911:CTTA:C | donor_loss | 1.0000 |
| 2:189753912:TTA:T | donor_loss | 1.0000 |
| 2:189753913:TACCA:T | donor_loss | 1.0000 |
| 2:189753914:A:AC | donor_gain | 1.0000 |
| 2:189753914:ACCA:A | donor_loss | 1.0000 |
| 2:189753915:C:CA | donor_loss | 1.0000 |
| 2:189753915:C:CC | donor_gain | 1.0000 |
| 2:189753915:CCAGT:C | donor_gain | 1.0000 |
| 2:189754061:ATACC:A | acceptor_loss | 1.0000 |
| 2:189754063:ACCT:A | acceptor_loss | 1.0000 |
| 2:189754066:T:C | acceptor_loss | 1.0000 |
| 2:189754259:T:TA | donor_gain | 1.0000 |
| 2:189755408:C:CA | donor_gain | 1.0000 |
| 2:189755422:AAGT:A | donor_gain | 1.0000 |
| 2:189755425:T:TA | donor_gain | 1.0000 |
| 2:189689518:A:AG | acceptor_gain | 0.9900 |
| 2:189689519:T:G | acceptor_gain | 0.9900 |
| 2:189689522:TGAA:T | acceptor_loss | 0.9900 |
| 2:189689525:A:AG | acceptor_gain | 0.9900 |
| 2:189689525:AGG:A | acceptor_loss | 0.9900 |
| 2:189689526:G:GG | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000017156 (2:189762886 G>A,T), RS1000081282 (2:189757267 A>G), RS1000194293 (2:189760565 G>T), RS1000234123 (2:189701965 A>G), RS1000272757 (2:189724144 A>C), RS1000289538 (2:189702238 A>C,G), RS1000333517 (2:189700957 T>A), RS1000501457 (2:189737389 A>G), RS1000531709 (2:189673750 A>G,T), RS1000538019 (2:189757769 C>A,T), RS1000591391 (2:189756153 T>G), RS1000595148 (2:189675090 C>G,T), RS1000681241 (2:189680019 C>A), RS1000713176 (2:189681817 T>C), RS1000744355 (2:189674530 C>T)
Disease associations
OMIM: gene MIM:609803 | disease phenotypes: MIM:613796, MIM:614162, MIM:614892, MIM:612313
GenCC curated gene-disease
Mondo (4): immunodeficiency 31B (MONDO:0013427), autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome (MONDO:0013599), Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency (MONDO:0013956), chromosome 2q32-q33 deletion syndrome (MONDO:0012864)
Orphanet (5): Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency (Orphanet:319595), Susceptibility to viral and mycobacterial infections due to STAT1 deficiency (Orphanet:391311), STAT1-related autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome (Orphanet:391487), 2q32q33 deletion syndrome (Orphanet:251019), SATB2-associated syndrome due to a pathogenic variant (Orphanet:576283)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_565 | Obesity-related traits | 6.000000e-06 |
| GCST002578_1 | Ferritin levels | 2.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003939 | energy intake |
| EFO:0004459 | ferritin measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C567350 | Chromosome 2q32-Q33 Deletion Syndrome (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| dimethylselenide | increases expression, increases oxidation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| perfluorohexanesulfonic acid | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Melphalan | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Hydroxyl Radical | increases expression, increases oxidation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, chromosome 2q32-q33 deletion syndrome, immunodeficiency 31B, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency